Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide in colds due to enterovirus/rhinovirus
NCT04489381Phase 3Terminated
- Sponsor
- Romark Laboratories
- Start
- Aug 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in common cold, sponsored by Romark Laboratories. Started Aug 2020; status: terminated.
02
Drugs
nitazoxanide
03
Conditions
common cold
Beyond the preview
Go deeper on NCT04489381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04489381.